Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
James Yu MD, MHS

James B Yu MD, MHS

Associate Professor, Department of Therapeutic Radiology, Yale School of Medicine; Director of Prostate and Genitourinary Cancers Radiotherapy Program, Yale Medicine, New Haven, CT.

James Yu, MD, MHS, is the director of Yale Medicine’s Prostate & Genitourinary Cancer Radiotherapy Program. A radiation oncologist, Dr. Yu specializes in treating genitourinary cancers such as kidney, bladder and prostate, central nervous system cancers and cases requiring Gamma Knife stereotactic radiosurgery.  

As a former Yale Center for Clinical Investigation scholar and member of the Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center at Yale, Dr. Yu’s research centers on the comparative effectiveness of new radiation technologies and how these new technologies are adopted nationally. Dr. Yu is currently a Senior Editor of the journal Practical Radiation Oncology, and is on the editorial boards of the Journal of Clinical Oncology, Journal of Clinical Oncology - Clinical Cancer Informatics, Journal of Surgical Oncology, Journal of the National Cancer Institute (JNCI), JNCI-Cancer Spectrum, European Urology Oncology, and Oncology (Williston Park).


Receive(d) Research Funding from: 21st Century Oncology and is a consultant for Augmenix Inc.